Literature DB >> 1689894

Oral glucose tolerance test in liver recipients treated with FK 506.

L Mieles1, S Todo, J J Fung, A Jain, H Furukawa, M Susuki, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689894      PMCID： PMC2903886     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  FK-506 in experimental renal allografts.

Authors:  D S Collier; R Calne; S Thiru; P J Friend; S Lim; D J White; H Kohno; J Levickis
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis.

Authors:  J O Ruiz; R L Simmons; C O Callender; C M Kjellstrand; T J Buselmeier; J S Najarian
Journal:  Surgery       Date:  1973-05       Impact factor: 3.982

3.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients.

Authors:  L Ost; G Tydén; I Fehrman
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

5.  Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.

Authors:  D Roth; M Milgrom; V Esquenazi; L Fuller; G Burke; J Miller
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939
  5 in total
  14 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.

Authors:  C Ricordi; Y Zeng; R Alejandro; A Tzakis; P Carroll; H L Rilo; R Venkataramanan; J J Fung; D Bereiter; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

3.  Effect of FK 506 on function of human islets of Langerhans.

Authors:  H L Rilo; Y Zeng; R Alejandro; P B Carroll; D Bereiter; R Venkataramanan; A G Tzakis; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

Authors:  P B Carroll; H Rilo; J Reyes; R Alejandro; Y Zeng; C Ricordi; A Tzakis; R Shapiro; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Effect of the immunosuppressant FK 506 on insulin release from adult rat islets of Langerhans.

Authors:  P B Carroll; A A Gonçalves; A C Boschero; A G Tzakis; T E Starzl; I Atwater
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans.

Authors:  P B Carroll; A C Boschero; M Y Li; A G Tzakis; T E Starzl; I Atwater
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

8.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

9.  Long-term insulin requirement after liver transplantation with FK 506 in American veterans.

Authors:  J Tabasco-Minguillan; L Mieles; P Carroll; J Gavaler; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

10.  Adverse effects of FK 506 overdosage after liver transplantation.

Authors:  M Alessiani; U Cillo; J J Fung; W Irish; K Abu-Elmagd; A Jain; S Takaya; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.